Midseason Influenza Vaccine Use by Adults in the U.S.: Detailed Survey Data Tables

Midseason Influenza Vaccine Use by Adults in the U.S.: Detailed Survey Data Tables
Source: RAND Corporation

In mid-November, RAND conducted a survey of a nationally representative sample of adults age 18 and over (n=3,969) to collect data on the receipt of the influenza vaccine in the United States. The detailed survey data presented here will inform public health officials and other stakeholders about progress toward vaccinating adults prior to the end of the vaccination season in late winter while action can still be taken to improve vaccination rates for this flu season. In particular, it provides information on vaccination rates for adults with one or more of the following indications: age 50 or older; having a high-risk health condition; being a health-care worker; or those who have contact with or are caring for young children, elderly, or high-risk individuals.

+ Mid-Season Influenza Vaccine Use by Adults in the U.S.
+ Full Document (PDF; 164 KB)

Comments are closed.